448 related articles for article (PubMed ID: 36774935)
21. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
[TBL] [Abstract][Full Text] [Related]
22. Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.
Xiong Y; Wang L; Pan Y; Wang M; Schwamm LH; Duan C; Campbell BCV; Li S; Hao M; Wu N; Cao Z; Wu S; Li Z; Wang Y
Stroke Vasc Neurol; 2024 Jun; ():. PubMed ID: 38858097
[TBL] [Abstract][Full Text] [Related]
23. Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial.
Xiong Y; Campbell BCV; Fisher M; Schwamm LH; Parsons M; Li H; Pan Y; Meng X; Zhao X; Wang Y
Stroke Vasc Neurol; 2024 Feb; 9(1):82-89. PubMed ID: 37247876
[TBL] [Abstract][Full Text] [Related]
24. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
[TBL] [Abstract][Full Text] [Related]
25. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
[TBL] [Abstract][Full Text] [Related]
26. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.
Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Dowling RJ; Bush SJ; Dewey HM; Thijs V; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bailey P; Rice H; de Villiers L; Scroop R; Collecutt W; Wong AA; Coulthard A; Barber PA; McGuinness B; Field D; Ma H; Chong W; Chandra RV; Bladin CF; Brown H; Redmond K; Leggett D; Cloud G; Madan A; Mahant N; O'Brien B; Worthington J; Parker G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
Int J Stroke; 2018 Apr; 13(3):328-334. PubMed ID: 28952914
[TBL] [Abstract][Full Text] [Related]
27. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
[TBL] [Abstract][Full Text] [Related]
28. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
Warach SJ; Dula AN; Milling TJ
Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
[TBL] [Abstract][Full Text] [Related]
29. Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial.
Nair R; Singh N; Kate M; Asdaghi N; Sarmiento R; Bala F; Coutts SB; Horn M; Poppe AY; Williams H; Ademola A; Alhabli I; Benali F; Khosravani H; Hunter G; Tkach A; Manosalva Alzate HA; Pikula A; Field T; Trivedi A; Dowlatshahi D; Catanese L; Shuaib A; Demchuk A; Sajobi T; Almekhlafi MA; Swartz RH; Menon B; Buck BH
Stroke Vasc Neurol; 2024 Jan; ():. PubMed ID: 38296590
[TBL] [Abstract][Full Text] [Related]
30. Tenecteplase versus alteplase after acute ischemic stroke at high age.
Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
[TBL] [Abstract][Full Text] [Related]
31. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
Wei H; Fu B; Yang C; Huang M
Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
[TBL] [Abstract][Full Text] [Related]
33. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
Hanley DF; Lane K; McBee N; Ziai W; Tuhrim S; Lees KR; Dawson J; Gandhi D; Ullman N; Mould WA; Mayo SW; Mendelow AD; Gregson B; Butcher K; Vespa P; Wright DW; Kase CS; Carhuapoma JR; Keyl PM; Diener-West M; Muschelli J; Betz JF; Thompson CB; Sugar EA; Yenokyan G; Janis S; John S; Harnof S; Lopez GA; Aldrich EF; Harrigan MR; Ansari S; Jallo J; Caron JL; LeDoux D; Adeoye O; Zuccarello M; Adams HP; Rosenblum M; Thompson RE; Awad IA;
Lancet; 2017 Feb; 389(10069):603-611. PubMed ID: 28081952
[TBL] [Abstract][Full Text] [Related]
34. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
[TBL] [Abstract][Full Text] [Related]
35. In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
Ferguson E; Lang E
Ann Intern Med; 2022 Nov; 175(11):JC124. PubMed ID: 36315948
[TBL] [Abstract][Full Text] [Related]
36. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
Bracard S; Ducrocq X; Mas JL; Soudant M; Oppenheim C; Moulin T; Guillemin F;
Lancet Neurol; 2016 Oct; 15(11):1138-47. PubMed ID: 27567239
[TBL] [Abstract][Full Text] [Related]
37. Tenecteplase Versus Alteplase for Acute Stroke: Mortality and Bleeding Complications.
Murphy LR; Hill TP; Paul K; Talbott M; Golovko G; Shaltoni H; Jehle D
Ann Emerg Med; 2023 Dec; 82(6):720-728. PubMed ID: 37178103
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial.
Mazighi M; Köhrmann M; Lemmens R; Lyrer PA; Molina CA; Richard S; Toni D; Plétan Y; Sari A; Meilhoc A; Jandrot-Perrus M; Binay S; Avenard G; Comenducci A; Grouin JM; Grotta JC;
Lancet Neurol; 2024 Feb; 23(2):157-167. PubMed ID: 38267188
[TBL] [Abstract][Full Text] [Related]
39. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
Goyal M; Menon BK; van Zwam WH; Dippel DW; Mitchell PJ; Demchuk AM; Dávalos A; Majoie CB; van der Lugt A; de Miquel MA; Donnan GA; Roos YB; Bonafe A; Jahan R; Diener HC; van den Berg LA; Levy EI; Berkhemer OA; Pereira VM; Rempel J; Millán M; Davis SM; Roy D; Thornton J; Román LS; Ribó M; Beumer D; Stouch B; Brown S; Campbell BC; van Oostenbrugge RJ; Saver JL; Hill MD; Jovin TG;
Lancet; 2016 Apr; 387(10029):1723-31. PubMed ID: 26898852
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
Alexandrov AV; Köhrmann M; Soinne L; Tsivgoulis G; Barreto AD; Demchuk AM; Sharma VK; Mikulik R; Muir KW; Brandt G; Alleman J; Grotta JC; Levi CR; Molina CA; Saqqur M; Mavridis D; Psaltopoulou T; Vosko M; Fiebach JB; Mandava P; Kent TA; Alexandrov AW; Schellinger PD;
Lancet Neurol; 2019 Apr; 18(4):338-347. PubMed ID: 30878103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
